HISTOCOMPATIBILITY STUDIES IN A CLOSELY BRED COLONY OF DOGS : II. INFLUENCE OF THE DL-A SYSTEM OF CANINE HISTOCOMPATIBILITY UPON THE SURVIVAL OF CARDIAC ALLOGRAFTS by Rapaport, Felix T. et al.
HISTOCOMPATIBILITY  STUDIES  IN  A  CLOSELY  BRED 
COLONY  OF  DOGS 
II.  INFLUENCE  OF  THE  DL-A  SYSTEI~I OF  CANINE  HISTOCOMPATIBILITY 
UPON  THE  SURVIVAL  OF  CARDIAC  ALLOGRAFTS* 
BY FELIX T. RAPAPORT,$  M.D., ARTHUR D. BOY]), M.D., FRANK  C. SPENCER, 
M.D.,  RICHARD  R.  LOWER,  M.D.,  JEAN  DAUSSET,  M.D., 
FLORENCE  D.  CANNON,  AND  JOSEPH  W.  FERREBEE,  M.D. 
(From the Department of Surgery, New York University Medical Center, New York, 10016, 
The Medical College of Virginia, Richmond, Virginia 23219, and the Mary [mogene 
Bassett Hospital (a~liated with Columbia University), Cooperstown, 
New York, 13326) 
(Received for publication 2 September 1970) 
Modern surgical technology has solved most, if not all, technical problems of cardiac trans- 
plantation in experimental animals (1) and in human subjects (2). Successful application of 
this new procedure to the treatment of end-stage cardiac disease has been hampered, however, 
by the host's recognition of a cardiac transplant as foreign tissue and his attempts to destroy 
the intruder through immunological responses normally used  as defenses against infectious 
microorganisms (3). 
Experimental heart transplantation began almost 65 years ago with the studies of Carrel 
and Guthrie (4, 5). A satisfactory experimental model for the investigation of host responses to 
cardiac allografts was not available, however, until 1933, when Mann et al.  (6) transplanted 
canine hearts to the necks of the recipients, with reestablishment of the coronary circulation by 
anastomosis of the host carotid artery to the donor aorta. This work, and a number of other 
studies (7-9) provided early evidence of the immunogenicity of cardiac allografts, which were 
usually rejected by the recipients within 4-8 days. The microscopic features of the rejected 
organs were characterized by the same type of mononuclear cell infiltrate and vascular change 
which has been associated with the acute rejection of other organ allografts (7, 10, 11). 
The potential usefulness of cardiac allografts in supporting the circulation of the host was 
considered "a matter of fantastic speculation for the future" as late as 1951 (12). The advent of 
the heart-lung machine, and  the studies of Lower and  Shumway  (13)  made this fantastic 
speculation a reality by 1960. Through the combined use of topical hypothermia for preserva- 
tion of the anoxic myocardium, anastomosis of the donor heart atrial walls and atrial septum to 
the posterior atrial wall and septum of the recipient, and joining of the aortic and pulmonary 
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arteries of donor and recipient, Lower and Shumway completed the first series of technically 
successful orthotopic canine cardiac allografts at that time, with a survival range of 6-21 days 
in five recipients (13). The method of Lower and Shumway has resulted in cardiac transplants 
fully capable of maintaining the host's circulation (14), leaving the immunological barrier as 
the last serious obstacle to the continued functioning  of such allografts for the normal life span 
of the recipient (15). As a result of immunological rejection responses,  the average survival 
time of cardiac allografts performed in randomly selected unmodified mongrel dogs has been 
reported as 7 days, with a range of 4-21 days (16). Treatment of recipients with immunosup- 
pressive drugs, such as azathioprine and methyl prednisolone, has prolonged survival to a 
range of 2-18 months (1, 16, 17). More recently, the use of anti-lymphocyte globulins has, on 
occasion, resulted in even longer survivals, as reported by Cachera, Dubost, Halpern, and asso- 
ciates (18, 19). 
These studies have provided a valuable background of information on the criteria for the 
diagnosis of impending rejection crises, and on the pathological changes associated with cardiac 
allograft rejection. It is generally agreed that serial electrocardiographic study, with particular 
regard to voltage drops and conduction abnormalities, may provide the most reliable early sign 
of impending rejection, and that the prompt and judicious use of immunosuppressive agents 
may reverse such crises (20-22). The resulting long-term survivals have also facilitated a more 
precise  analysis of the different pathological parameters of cardiac allograft rejection. Acute 
cardiac allograft rejections which usually occur during the first  two postoperative weeks are 
characterized by mononuclear cell infiltration of the myocardium, with capillary and venular 
damage (including endothelial swelling and necrosis, vascular engorgement, multiple thrombi, 
and disruption of some vessels) with exudation of fibrin and erythrocytes, and with multiple 
foci of myocytolysis and myocyte necrosis. In contrast, the chronic type of rejection observed 
in allografts accorded longer survival times consists mainly of a diffuse destructive arteritis, 
intimal fibrosis with luminal narrowing, and resulting myocardial ischemia (23, 24). The acute 
and chronic types of cardiac ailograft rejection would therefore appear to be very similar to the 
changes described for renal ailografts by Porter and his associates  (25--28). 
The careful experimental work in canine cardiac transplantation culminated in the first 
technically successful human cardiac transplant, performed by Barnard in 1967 (2). This event 
stimulated a world-wide effort to treat a variety of end-stage cardiac disease entities by trans- 
plantation. This effort, which rapidly gained epidemic proportions, resulted in the performance 
of 158 human cardiac allografts by 59 different  surgical  teams by April 1970 (29). It was also 
frequently associated  with ailograft failure and death of the patient (29). As had been shown 
previously in the canine species, modern surgery had conquered the technical aspects of cardiac 
surgery, but further progress was dependent upon the acquisition of a better understanding of 
the immunological  processes responsible for cardiac allograft failure (30-35). 
These  considerations suggest a  need for further  investigations of the host's 
immunological responses to cardiac allografts, with particular regard to a search 
for new methods to attenuate the tempo and intensity of the rejection response. 
The colony of closely bred beagles maintained in Cooperstown, New York,  by 
Ferrebee et al. (36) appeared to provide an unusually suitable source of experi- 
mental animals for this purpose.  Previous studies of the  Cooperstown beagles 
have demonstrated that the DL-A system of canine histocompatibility defined 
in this colony (37)  may play an important role in conditioning the survival of 
skin (38)  and kidney allografts (37). The present study describes the responses 
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and Swisher  erythrocyte-group antigens (39)  to  orthotopic  cardiac allografts 
obtained from donors selected on the basis of leukocyte and erythrocyte group 
compatibility with the recipients. The survival of such allografts is  compared 
with the behavior of  28  orthotopic cardiac allografts performed in randomly 
selected mongrel dogs. The results indicate that DL-A compatibility exerts a 
potent influence  upon the survival of cardiac allografts in the unmodified canine 
host (i.e., a recipient whose immunological  responsiveness has not been altered 
by preexisting disease or imnlunosuppressive  therapy). This influence is exerted 
more profoundly in littermates than in recipients of nonlittermate transplants. 
Comparison of  cardiac  and  renal  (37)  aUografts  under similar conditions of 
donor-recipient DL-A compatibility suggests that  the heart may be less  im- 
munogenic than the kidney. Cardiac  allografts appear,  however,  to be more 
vulnerable to allograft rejection than renal transplants. 
Materials and Methods 
Criteria for Selection of Experimental Animals.--A closely bred colony of beagles of known 
leukocyte (DL-A) groups (37) and randomly selected mongrel dogs were used throughout this 
study. Male and femal~  dogs weighing 18-25 lb. were maintained on a standard diet. Coopers- 
town beagle donor-recipient pairs were selected for cardiac transplantation  on the basis of (a) 
coefficients of relationship (siblings and nonlittermates),  (b) Swisher erythrocyte group anti- 
gens A, C, and D, and (c) leukocyte group (DL-A) compatibility. 
The erythrocyte  antigens were detected with the typing sara and techniques of Swisher 
(39). A battery of antisera prepared by reciprocal exchanges of skin allografts and subcuta- 
neous inoculations of blood leukocytes in five  pairs of beagle littermates and in two nonlitter- 
mate pairs (38) was employed to identify 11 currently known DL-A leukocyte group antigens, 
b, c, d, e, f, g, h, j, k, 1, andm, inthe  Cooperstown beagles. The technique of lymphocytotoxicity 
described by Epstein et ah (40) was employed, but with removal of erythrocytes by sedimen- 
tation before nylon filtration  for the  separation  of lymphocytes from polymorphonuclear 
eukocytes. This technique yielded a 90% lymphocyte population in the final cell suspension. A 
lmodification of this technique has been instituted recently, whereby this cell preparation is re 
suspended in veronal-buffered saline solution before performance of the lymphocytotoxicity 
test. This modification has significantly enhanced the sensitivity of the typing procedure, and 
has permitted identification of a number of DL-A phenotypes in which antigens f and m, and g 
and 1  do not occur together. These antigens are therefore no longer expressed in paired fashion 
(37) in the beagle phenotypes listed in the present study. 
Previous results of a limited number of skin (38) and kidney (37) allografts in the Coopers- 
town beagles have suggested that DL-A antigens e, f, g, 1  and m may be strong histocompati- 
bility antigens, and constitute major barriers to transplantation,  while DL-A antigens b, c, d, 
h, j, and k behave as weak antigens, and may therefore constitute a major threat to allograft 
survival. The present study extends the same criteria of donor-recipient compatibility to an 
assessment of cardiac allograft responses in this colony of beagles. 
Method of Cardiac Transplantation and Determination of Allograft Rejection.--The technique 
of orthotopic canine cardiac allotransplantation  of Lower and Shumway (13, 14) was used, 
with some modifications,  throughout this study. Donors and recipients were anesthetized with a 
30 mg/kg dose of pentobarbitai (Abbott Laboratories, North Chicago, Ill.) and received 3 mg/kg 
of heparin sodium (Organon, Inc., West Orange, N. J.).  The operative fields were exposed 
through a median sternotomy incision. Cardiopulmonary bypass was instituted in the recipient RAeAPORT ET  AL.  263 
utilizing the femoral artery for arterial return, with venous drainage into a standard pump 
oxygenator which was primed with fresh blood obtained from five mongrel dogs and was con- 
nected with cannulas placed through the right atrium and into the superior and inferior vena 
cavae of the recipient. The oxygenated blood flow rate was 100 cc/kg throughout the period of 
bypass. The recipient's aorta and pulmonary artery were occluded with a clamp placed through 
the transverse sinus, and the heart was excised, leaving the host's posterior atrial walls and 
septum in place. 
The donor heart was excised in similar fashion; it was immediately placed for 20 rain in 
psysiological salt solution maintained  at a temperature  of 4°C. Sutures approximating the 
superior and inferior edges of the interatrial septa of donor and recipient were inserted; the 
septa were anastomosed, followed by anastomosis of the right atria. The aortic anastomosis 
was then performed and a venting catheter was inserted into the left ventricle through the left 
atrial appendage and mitral valve. The coronary circulation was restored by unclamping the 
aorta, the left atrium was closed, and the heart was defibrillated by electric shock. The pulmo- 
nary anastomosis was completed at this time and the cardiopulmonary bypass was discon- 
tinued after an additional 15 min of support. After careful hemostasis, a chest tube was inserted 
into the left thoracic cavity and was connected for the next 24 hr to external underwater drain- 
age. The median sternotomy was then closed, and routine postoperative care for cardiac opera- 
tions was given. The latter included antibiotic therapy for 2 wk, consisting of intramuscular 
injections of 500 mg per day of Polycillin (ampicillin trihydrate,  Bristol-Myers Co., Syracuse, 
N. Y.), and 1 g per day of Staphcillin (sodium methicillin, Bristol-Myers Co.). 
The recipient's arterial and central venous pressures, hematocrits, PO2, pCO2, and pH 
levels were monitored at regular intervals during the immediate postoperative period (41, 42). 
The cardiac and respiratory rate, temperature, hematocrit, white blood count level, and elec- 
trocardiogram were monitored daily until the time of allograft rejection. The onset of rejection 
was regularly heralded by changes in voltage of the electrocardiogram, particularly in the R- 
wave (1). The diagnosis of rejection was confirmed in each instance by death of the animal and 
pathological examination of the transplanted heart. 
RESULTS 
The  results  of  56  cardiac  allografts performed  during this  study are  sum- 
marized in Table I. The first group of animals included six beagles grafted with 
major I)L-A antigen-compatible transplants obtained from  littermates. The 
allografts were rejected in 22, 24, 31,  72,  80, and 90 days respectively, with a 
mean survival time (MST) 1 of 53.2 days. The MST of seven hearts transplanted 
to  littermates from major DL-A  antigen-incompatible donors was  7.3  days, 
with a span of 5-10 days. The next two groups of animals included recipients of 
hearts  obtained from nonlittermate donors.  Nine recipients of  major I)L-A 
antigen-compatible donors had an MST of 26.3 days, with a  survival span of 
10-55 days; six dogs survived for 21 days or more. In contrast, the MST of six 
transplants obtained from major DL-A antigen-incompatible donors was 6.3 
days, with a span of 4-9 days. The last group of animals included 28 transplants 
performed in randomly selected outbred mongrel dogs. The MST of these allo- 
grafts was 10.0 days, with a span of 4-19 days; one additional allograft survived 
for 30 days. 
1 Abbreviation used in this paper: MST, mean survival time. 264  I-IISTOCOMPATIBILITY STUDfES  IN  DOGS.  II 
~q 
to 
8~ 
o RAPAPORT  ET  AL.  265 
The DL-A and erythrocyte group antigens of 11 littermate and nonlittermate 
recipients  of  DL-A-compatible  allografts  are  listed  in  descending  order  of 
histocompatibility (as gauged by survival times) in Table II. The MST of five 
TABLE II 
Rdationship  Between DL-A  Compatibility  and  Cardiac Allograft  Survival  in  a  Closely Bred 
Colony of Beagles. (a) Transplants  Obtained From Compatible Donors 
Erythrocyte  Cardiac  DL-A antigens in  antigens in  Donor-  No.  Recip-  Donor  allograft 
recipient  of  ient  No.  survival 
relationships  ani-  No.  Recip-  Donor  time  mals  Recipient  Do nor  lent 
Littermates 
(Days) 
5  20-66  20-67  g, 1  g, 1  C  C  90 
21-33  21-28  b, c, d, e,  f, k, m  b, c,  f, k, m  A  C*  80 
21-13  21-12  e,  f, g, 1, m  e, f, g, l, m  AC  AC  72 
21-20  21-21  b, c, d, e, f, k, m  b, c, d, e,  f, k, m  A  A  31 
20-33  20-38  b, f, g, k, 1, m  g, 1  AC  AC  22 
MST: 59.0 
Nonlittermates  6  20-84  20-31  g, 1  g, I  AC  AC  44 
21-23  21-35  b, c, d, f, k, m  b, c, d, f, k, m  C  AC*  30 
20-95  20-80  b, f, k, m  b, f, k, m  AC  AC  23 
17-57  16-89  g, l  g, 1  None  ACD*  23 
21-98  21-07  b, f, k, m  b, f, k, m  C  AC*  17 
20-76  21-22  b, f, k, m  b, f, k, m  AC  C  10 
MST: 24.5 
* Presence in the donor of an erythrocyte antigen (Swisher) absent in the recipient. 
TABLE III 
Rdationships Between DL-A  Compatibility  and  Cardiac Allograft  Sur~qval in a Closely Bred 
Colony of Beagles. (b) Transplants  Obtained from Donors Differing from the Recipients 
by Weak DL-A Antigens* 
Donor-  Recip- 
recipient  lent  Donor 
relationship  No.  No. 
DL-A antigens in 
Recipient  Donor 
Erythrocyte  DL-A  Eryth-  Cardiac 
antigens in  rocyte  allograft  antigen  antigen 
incom-  incom-  survival 
ReciP-ient  Donor  patibility patibility  time 
Litter-  20-51  20-52  g, 1  b, c,  g, k, 1  C  None  b, c, k  -- 
mates 
Nonlitter-  20-99  21-01  b, e,  f, g, k, 1, m  b, c, f, k, m  --  A  c  A  55 
mates  21-45  21-27  b, f, g, k, 1, m  b, c, d, f, k, m  --  AC  c, d  A, C  21 
21-44  21-19  b, f, g, k, 1, m  b, c,  d, g, k, 1  AC  C  c, d  --  14 
(Days) 
24 
* DL-A Antigens b, c, d, and k. 
DL-A-compatible transplants  obtained from littermate donors was 59.0 days 
(span 22-90 days). In contrast, the MST of six DL-A-compatible transplants 
obtained from nonlittermate donors was 24.5 days, with a span of 10-44 days. 
Table III summarizes the results observed when cardiac allografts were per- 266  HISTOCOMPATIBILITY  STUDIES  IN  DOGS.  II 
formed across weak DL-A barriers (i.e., incompatibilities for antigens b, c, d, or 
k). One littermate transplant performed under such conditions survived for 24 
days, and three other allografts obtained from nonlittermate donors were ac- 
corded survival times of 14, 21, and 55 days respectively. The longest survival 
TABLE IV 
Rdationship  Between DL-A  Compatibility  and  Cardiac  Allograft  Survival  in  a  Closely Bred 
Colony of Beagles.  (c) Transplants Obtained from Donors Differing from the Recipients 
by Strong DL-A Antigens* 
Erythrocyte  Eryth- 
DL-A antigens in  antigens in  rocyte  Cardiac 
Donor-  Recip-  Donor  DL-A antigen  antigen  allograft 
recipient  lent  No.  incompatibility  incom-  survival 
relationship  No.  Recipient  Donor  Recipient  Donor  patibil-  time 
ity 
(Days) 
Litter-  21-10  21-11  e,  g, l, m  f, g, 1, m  A, C, D  A, C  f  --  10 
mates  (7  17-07  17-11  e,  g, 1  e,  f, h, k, m  A, C  A, C  f, h, k, m  --  9 
Dogs)  20-68  20-69  g, 1  f, g,  1  C  C  f  --  8 
21-36  21-38  g, 1  f, g,  I  C  C  f  --  7 
21-17  21-18  g, 1  b, e,  g, k,  1  AC  A  b,  e, k  --  6 
20-91  20-90  b,  f, g, k,  b,  e,  f, g, k,  AC  AC  e  --  6 
1, m  l, m 
20-97  21-09  b,c,e,  f,  f,g,l,m  A  A,C,D  m  C,D  5 
g, k, 1 
MST:  7.3 
Nonlitter- 
mates  (6 
Dogs) 
17-79  16-93  b,  e, g, k,  b, f, g, h, j,  None  None  b,  f, h, j, k, m  --  9 
1  k,  1, m 
20-73  21-05  g, 1  b,  f, k, m  C  C  b,  f, k, m  --  7 
21-15  21-29  g, 1  b,c,d,f,k,  A  C  b,e,d.f,k,  C  6 
m  m 
20-72  20-23  g, 1  f,g,l,m  C  A,C,D  f,m  A,D  6 
20-96  21-08  b, c, e,  f,  g, 1, m  A  A, C, D  m  C, D  6 
g, k,  1 
16-80  17-75  b, e,  g, 1  b,  f, g, h, j,  A  A,C  f, h, j,k,m  C  4 
k,l,m 
MST:  6.3 
* Antigens e,  f, g, 1, and m, 
(55 days) occurred in the face of a donor-recipient incompatibility for antigen 
c only. 
5 of the 15 cardiac allografts listed in Tables II and III were performed across 
donor-recipient incompatibilities for Swisher erythrocyte antigens A, C, and/or 
D. The results show no direct evidence that such incompatibilities had an ad- 
verse influence upon the duration of cardiac allograft survival. 
The effects of donor-recipient incompatibilities for DL-A antigens e, f, g,  1, 
and m  are illustrated in Table IV, which summarizes the results of 13 cardiac 
allografts performed under such  conditions. The MST  of seven cardiac allo- ¢o 
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grafts obtained from DL-A-incompatible littermate donors was 7.3 days, with 
a span of 5-10 days. Six transplants performed under similar conditions in non- 
littermates had an MST of 6.3 days, with a span of 4-9 days. The five donor- 
recipient erythrocyte antigen  incompatibilities  observed in  these  13  animals 
were associated with the shortest cardiac allograft survival times (~6 days). 
An interpretation of this result is hampered, however, by the documented effects 
of donor-recipient incompatibilities for known and/or as yet undetectable major 
DL-A antigens. 
Two other cardiac allografts obtained from nonlittermate donors who had 
no serologically detectable DL-A incompatibilities with the recipients were re- 
jected in 8 and 5 days respectively. In contrast, when donor and recipient were 
genotype as well as phenotype identical in the DL-A system, the longest cardiac 
allograft survival in the present series (90 days) was  observed. These results 
TABLE VI 
Comparative  Survival of Cardiac  and  Renal Allografls in Beagles of Known  DL-A  Phenotypes 
Mean survival time In  Survival range 
Genetic status of  Organ  No. of  trans-  DL-A-  DL-A-in-  DL-A-  DL-A-in- 
donor and recipient  transplanted  plants  compatible  compatible  compatible  compatible 
transplants  transplants  transplants  transplants 
(Days  (Days)  (Days)  (Days) 
Littermates  Heart  13  53.2  7.3  22-90  5-10 
Kidney  21  28.6  14.8  13-38  11-20 
Nonlittermates  Heart  15  26.3  6.3  10-55  4-9 
Kidney  28  28.3  12.4  16-45  10-18 
highlight the need for further genetic data in order to facilitate interpretation of 
the results of currently available serological techniques in the DL-A system. 
The results of cardiac and renal allografts performed in the same population 
of randomly selected mongrel dogs are compared in Table V. The MST of 28 
cardiac allografts was 10.0 days, with a span of 4-31 days, and the MST of 21 
renal allografts performed under similar conditions was 9.5  days, with a span 
of 4-16 days.  Table VI  lists  a  similar comparison in  beagle donor-recipient 
combinations selected on the basis of DL-A compatibility. It is of interest that 
the  MST  of  DL-A-compatible  cardiac  allografts  obtained  from  littermate 
donors (53.2  days) was significantly greater than the MST of renal allografts 
performed under similar conditions (28.6 days). Conversely, the MST of cardiac 
allografts performed in DL-A-incompatible littermates (7.3  days) was signifi- 
cantly shorter than the survival of renal transplants done under such circum- 
stances (14.8 days). There were no great differences, however, between cardiac 
(MST =  26.3 days) and renal (MST =  28.3 days) allograft survivals in DL-A RAPAPORT  ET AL.  269 
compatible nonlittermate beagles.  Cardiac allografts performed in DL-A in- 
compatible nonlittermates survived for  shorter  periods  (MST  =  6.3  days), 
however,  than  the  corresponding renal  allografts  (MST  =  12.4  days).  Sex 
differences or coefficients in relationship in the nonlittermate beagles did not 
appear to play a significant role in these results. 
DISCUSSION 
The elegant studies of Epstein et al. (40) have demonstrated that cross-im- 
munization of canine littermates with buffy coat cells can stimulate the forma- 
tion of leukocyte group-specific antisera, and that the latter may be of value 
in the selection of compatible donor-recipient combinations for bone marrow 
transplantation in littermates (4) and in unrelated dogs (43). Mollen et al. (38) 
and Ferrebee  et al.  (36)  have recently isolated 11  different leukocyte group 
specificities in the Cooperstown colony of closely bred beagles (44).  The ob- 
servation that such antigens behave as Mendelian autosomal dominants in this 
colony of dogs  (36),  taken together with their role  in  conditioning host re- 
sponses to skin (38) and kidney (37)  allografts, have suggested that the same 
general rules of histocompatibility encountered in the murine H-2 system (45) 
and in the human HL-A system (46) may also be operative in the canine species, 
and have led to the suggestion that the term DL-A be adopted for this system 
in dogs (37). 
The results of the present study indicate that the major leukocyte group 
antigens detectable by Mollen et al.'s (38) battery of typing antisera play an 
important role in conditioning the survival of cardiac allografts in the Coopers- 
town colony of beagles. As has been noted previously for bone marrow (44), 
skin (38),  and kidney (37)  transplants, donor-recipient coefficients of correla- 
tion in nonlittermates or erythrocyte-group incompatibility did not appear to 
play decisive roles as determinants of cardiac allograft survival. There were 
significant differences, however, between the results of cardiac transplantation 
in littermate and nonlittermate dogs. 
The  results  of cardiac allografts performed under  conditions of donor-re- 
cipient  DL-A  compatibility were  uniformly better  than  those  observed  in 
randomly selected mongrel dogs (MST =  10.0 days). DL-A-compatible trans- 
plants performed in littermates were accorded far longer survival times, how- 
ever,  than  the  corresponding  allografts performed  in  nonlittermate beagles 
(MST =  53.2 days in littermates and 26.3 days in nonlittermates). This obser- 
vation provides a possible explanation for an earlier report by Leandri-Cesari 
et al. (47) that the longest survival times of cardiac allografts are observed in 
littermate  transplants.  Cardiac  allografts performed across  major DL-A  in- 
compatibilities exhibited significant decreases in survival in littermate as well 
as nonlittermate donor-recipient combinations (MST  =  7.3 and 6.3 days, re- 
spectively). These findings are consistent with the interpretation that, as has 270  HISTOCOMPATIBILITY STUDIES  IN  DOGS.  II 
been suggested for the H-L-A system in man (32),  currently available DL-A- 
typing sera may have a greater ability to select optimally compatible donor- 
recipient combinations in littermates (i.e. siblings)  than in nonlittermates. It is 
of interest, however, that transplants performed across major DL-A incompati- 
bilities are accorded comparable decreases in survival time in both groups. The 
latter results were less favorable than those noted in randomly selected mongrel 
dogs, possibly because prospective DL-A typing succeeded in eliminating from 
the DL-A-incompatible group the chance-compatible donor-recipient combina- 
tions which may occur when transplants are performed in a randomly selected 
population. 
The  present  study extends  to heart  transplantation previous  suggestions, 
based upon results of skin (38) and renal (37) allografts, that antigens e, f, g, l, 
and m may be strong histocompatibility antigens, constituting major barriers 
to allotransplantation, while antigens b, c, d, and k may be less effective in this 
regard. A  cardiac allograft obtained from a  nonlittermate donor whose only 
incompatibility with the recipient was antigen c survived for 55  days. Three 
other donor-recipient combinations with incompatibilities for antigens b, c, d, 
and/or k resulted in cardiac allograft survival times of 14, 21, and 24 days re- 
spectively. Although these data are insufficient to warrant any defiaitive con- 
clusions,  they would appear to suggest that, as has been noted for the murine 
species  (48),  incompatibilities for weak histocompatibility antigens may exert 
an additive effect. 
Performance of cardiac and renal allografts in the same colony of beagles, 
under controlled conditions of donor-recipient DL-A-compatibility, has pro- 
vided a useful opportunity for a biological assessment of the comparative im- 
munogenicity of these two organs. The significantly longer survival of cardiac 
as compared with renal allografts in DL-A-compatible littermate animals is in 
a~reement with previous observations suggesting that cardiac tissue may be less 
immunogenic than renal tissue (49, 50). The very short survival of cardiac allo- 
grafts performed in major DL-A-incompatible donor-recipient combinations 
provides  convincing evidence  however  that,  as  has  been  suggested  by van 
Bekkum and his associates (51, 52),  the heart may be more vulnerable to allo- 
graft rejection than the kidney. Such a difference in the ability of the heart and 
kidney to withstand the effects of the rejection response may be a reflection of 
actual differences in the concentration of histocompatibility antigens (49, 50). 
It may also be a consequence of physiological differences in the susceptibility of 
these two organs to allograft rejection. In this regard, it may be pertinent to 
note that the pathological lesions  of allograft rejection have been found to be 
particularly prominent within cardiac conducting tissue. Such lesions  include 
endothelial edema and perivascular mononuclear cell  infiltrates in  the atrio- 
ventricular node, conduction bundles, and bundle branches (35, 53, 54). A pos- 
sible explanation for this finding is suggested by Clarke's demonstration of the RAPAPORT  ET  AL.  271 
particularly rich vascularity of the sinus node, atrioventicular node, and main 
conducting bundles (55). 
It is of interest that two cardiac allografts performed in nonlittermate dogs 
in  the  absence  of  serologically detectable  donor-recipient  incompatibilities 
were accorded unusually brief survival times (8 and 5 days respectively). In 
contrast, a cardiac allograft performed between DL-A-identical littermate dogs 
survived for 90 days. This observation highlights the concept that DL-A pheno- 
type identity, at the present level of understanding of DL-A serology, may not 
necessarily signify the absence  of incompatibility between donor and recipient 
in all instances. The fact that genetic DL-A identity is associated  with pro- 
longed allograft survival serves,  on the  other hand, to demonstrate the  pre- 
dominant role of the DL-A system, or of a gene closely linked to it, in canine 
transplantation. 
The results provide a  further illustration of the vicissitudes of tissue typing 
for organ transplantation, which appear to be common to most species studied. 
They highlight the need for a  further serologic definition of the known and the 
yet undetected antigenic components of the DL-A system. The evidence also 
supports the contention that use of the DL-A system on a prospective basis for 
the selection of those donor-recipient combinations which may result in long- 
term survival of the major transplantable organs is not only dependent upon 
currently available serological criteria of compatibility, but also upon a genetic 
analysis (i.e.  a family study) of the transmission of DL-A antigens to donor 
and recipient by their respective forebears.  Such  genetic studies may be  of 
particular value for the establishment of guidelines for further experimental 
approaches  to the  long-term facilitation of major  organ  transplant  survival 
in the mammalian host. 
SUMMARY 
The  DL-A  system  of  histocompatibility  plays  an  important  role  in 
conditioning the survival of cardiac allografts in the unmodified canine host, 
The mean survival  time  of  six  cardiac  allografts perfolTned  in  DL-A-com- 
patible  littermate dogs  obtained from a  closely bred  colony of beagles  was 
53.2  days, while the  MST  of  transplants  performed in  seven DL-A-incom- 
patible animals was 7.3 days. The MST of cardiac allografts performed in nine 
DL-A-compatible nonlittermate beagles was 26.3 days, as compared with 6.3 
days  in  six  DL-A-incompatible  nonlittermate  transplants.  The  results  did 
not  appear  to  be  affected  by  Swisher  erythrocyte-group  incompatibilities. 
The  MST  of  28  cardiac allografts performed  in  randomly selected mongrel 
dogs was 10.0 days. 
Incompatibilities for DL-A antigens e, f, g, 1, and m may constitute major 
barriers to transplantation, but antigens b, c, d, and k appeared to act as weak 
histocompatibility antigens. 272  HISTOCOMPATIBILITY  STUDIES IN  DOGS. II 
Under controlled conditions of donor-recipient DL-A compatibility,  cardiac 
allografts may be less immunogenic than renal transplants.  Heart  transplants 
performed  across  major  donor-recipient  DL-A  incompatibilities  appeared, 
however, to be more vulnerable to the events of allograft rejection than renal 
allografts performed under similar conditions. 
The  selection  of  optimally  compatible  donor-recipient  combinations  for 
organ transplantation  may be aided materially by genetic studies of the trans- 
mission of DL-A antigens to the animals under consideration. 
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